Mixed Reactions to Trump’s IVF Expansion Proposal

President Trump’s recent announcement about expanding access to in vitro fertilization (IVF) has evoked a range of responses from lawmakers, advocates, and medical organizations. While some see it as a positive step, others express skepticism regarding its effectiveness.

During a speech in the Oval Office, Trump unveiled new federal guidelines aimed at insurance coverage for IVF services, alongside agreements with pharmaceutical companies based on a “most-favored-nation” pricing model.

The updated guidelines from the Departments of Labor, Treasury, and Health and Human Services (HHS) make enrolling in fertility benefits akin to opting for dental or vision coverage within employer health plans.

EMD Serono, known for infertility treatments like Gonal-F, announced it would provide its “leading IVF treatments” at reduced prices, which includes exemptions from tariffs that the White House had previously threatened.

Trump referred to himself as the “father of in vitro fertilization” and had previously pledged to make IVF accessible either through government funding or mandated insurance coverage. However, the plan introduced does not align with those commitments.

Nevertheless, some fertility advocacy groups expressed support for the announcement. Moshe Margaretten, the head of Americans for IVF, described it as “a major step forward” in enhancing access to infertility treatment.

“While this step is important, our efforts are far from over. The President indicated today that this is just the start,” Margaretten noted. “We will continue to collaborate with the White House and Congress for further reforms to ensure all families dealing with infertility receive the support they need.”

Senator Katie Britt (R-Alabama) called the move “the most pro-IVF action by a president in U.S. history.”

Sean Tipton, policy director for the American Society of Reproductive Medicine, agreed but pointed out that these policies fall short of what the president aimed to accomplish—universal access to IVF. He acknowledged financial barriers as significant hurdles, especially in the U.S., but expressed concern that the plan relying on employers to cover infertility services lacks strong mandates.

“There’s no enforcement here—just incentives,” Tipton stated.

He noted that while presidential endorsement could aid in broader coverage, the measure isn’t equivalent to legislation, and it remains unclear how many employers would be willing to include such costly treatments, which can average $15,000 to $20,000 per cycle.

However, potential cost savings for Gonal-F treatments, priced around $5,000 to $6,000 per cycle, were acknowledged.

Senator Elizabeth Warren (D-Mass.) criticized the nature of these policies amidst ongoing healthcare coverage disputes. She claimed, “It’s evident that Trump misled the public about making IVF free for families.” Warren described the announcement as an insult and further evidence of Trump’s unfulfilled promises.

Criticism was also anticipated from anti-abortion groups, as unused embryos are often disposed of during IVF. When asked about this fallout, Trump dismissed the concerns, asserting his strong pro-life stance.

Marjorie Dannenfelser, president of the anti-abortion organization Susan B. Anthony Pro-Life America, emphasized that any policy in this domain must prioritize the lives of the youngest children and reiterated her group’s opposition to any destruction of human embryos. She called for higher ethical standards within the IVF industry.

The issue of embryo personhood was spotlighted in a controversial Alabama Supreme Court ruling last year, which classified frozen embryos as equivalent to children. This decision has resulted in a temporary halt of IVF services in Alabama, with clinics worried about potential legal ramifications.

Republican lawmakers find themselves navigating a complex situation. While some support the court’s ruling, they’re hesitant to restrict IVF services. Democrats have pointed to this controversy as part of a broader agenda to overturn Roe v. Wade, criticizing Trump for appointing justices who played a role in that decision.

Emily’s List, a key Democratic group that backs women candidates supporting abortion access, characterized Trump’s proposal as disappointing. President Jessica Mackler argued that while Republicans claim to care about women’s issues, they are, in reality, undermining health insurance for millions and making essential care less accessible.

“Real solutions for families seeking IVF are only achievable by reclaiming Congress and electing compassionate women leaders into office,” she added.